206 related articles for article (PubMed ID: 20357373)
41. The sensitivity of clinical diagnostic methods in the diagnosis of diabetic neuropathy.
Onde ME; Ozge A; Senol MG; Togrol E; Ozdag F; Saracoglu M; Misirli H
J Int Med Res; 2008; 36(1):63-70. PubMed ID: 18230269
[TBL] [Abstract][Full Text] [Related]
42. Quantitative assessment of diabetic peripheral neuropathy with use of the clanging tuning fork test.
Oyer DS; Saxon D; Shah A
Endocr Pract; 2007; 13(1):5-10. PubMed ID: 17360294
[TBL] [Abstract][Full Text] [Related]
43. Comparison of different screening tests for detecting diabetic foot neuropathy.
Forouzandeh F; Aziz Ahari A; Abolhasani F; Larijani B
Acta Neurol Scand; 2005 Dec; 112(6):409-13. PubMed ID: 16281925
[TBL] [Abstract][Full Text] [Related]
44. High Prevalence and Incidence of Diabetic Peripheral Neuropathy in Children and Adolescents With Type 1 Diabetes Mellitus: Results From a Five-Year Prospective Cohort Study.
Walter-Höliner I; Barbarini DS; Lütschg J; Blassnig-Ezeh A; Zanier U; Saely CH; Simma B
Pediatr Neurol; 2018 Mar; 80():51-60. PubMed ID: 29429781
[TBL] [Abstract][Full Text] [Related]
45. Validation of the Composite Autonomic Symptom Score 31 (COMPASS 31) for the assessment of symptoms of autonomic neuropathy in people with diabetes.
Greco C; Di Gennaro F; D'Amato C; Morganti R; Corradini D; Sun A; Longo S; Lauro D; Pierangeli G; Cortelli P; Spallone V
Diabet Med; 2017 Jun; 34(6):834-838. PubMed ID: 27990686
[TBL] [Abstract][Full Text] [Related]
46. Reproducibility of different methods for diagnosing and monitoring diabetic neuropathy.
Nasseri K; Strijers RL; Dekhuijzen LS; Buster M; Bertelsmann FW
Electromyogr Clin Neurophysiol; 1998; 38(5):295-9. PubMed ID: 9741007
[TBL] [Abstract][Full Text] [Related]
47. Rapid screening of diabetic polyneuropathy: selection of accurate symptoms and signs in an outpatient clinical setting.
Najafi L; Khamseh ME; Malek M; Baradaran HR; Aghili SM; Kia M; Aghili R
Acta Med Iran; 2014; 52(7):519-27. PubMed ID: 25135261
[TBL] [Abstract][Full Text] [Related]
48. A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes.
Papanas N; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Maltezos E
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):135-8. PubMed ID: 18095233
[TBL] [Abstract][Full Text] [Related]
49. [Joint diagnostic value of four temperature sensation tests in elderly patients with type 2 diabetic peripheral neuropathy].
Guo W; Li YM; Ai ZH; You ZQ; Wan Y; Cheng Y; Lang HM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Jul; 44(4):673-6. PubMed ID: 24059130
[TBL] [Abstract][Full Text] [Related]
50. Prevalence and characteristics of diabetic polyneuropathy in Passo Fundo, South of Brazil.
Tres GS; Lisbôa HR; Syllos R; Canani LH; Gross JL
Arq Bras Endocrinol Metabol; 2007 Aug; 51(6):987-92. PubMed ID: 17934667
[TBL] [Abstract][Full Text] [Related]
51. Early recognition of diabetic neuropathy: evaluation of a simple outpatient procedure using thermal perception.
Viswanathan V; Snehalatha C; Seena R; Ramachandran A
Postgrad Med J; 2002 Sep; 78(923):541-2. PubMed ID: 12357015
[TBL] [Abstract][Full Text] [Related]
52. Endothelin-1 predicts incident diabetic peripheral neuropathy in Type 2 Diabetes: a cohort study.
Pek SLT; Lim SC; Ang K; Kwan PY; Tang WE; Sum CF; Tavintharan S
Eur J Endocrinol; 2020 Apr; 182(4):429-438. PubMed ID: 32061157
[TBL] [Abstract][Full Text] [Related]
53. Variability in the clinical diagnosis of diabetic peripheral neuropathy.
Chicharro-Luna E; Pomares-Gómez FJ; Ortega-Ávila AB; Coheña-Jiménez M; Gijon-Nogueron G
Prim Care Diabetes; 2020 Feb; 14(1):53-60. PubMed ID: 31208891
[TBL] [Abstract][Full Text] [Related]
54. Hidden dangers revealed by misdiagnosed diabetic neuropathy: A comparison of simple clinical tests for the screening of vibration perception threshold at primary care level.
Azzopardi K; Gatt A; Chockalingam N; Formosa C
Prim Care Diabetes; 2018 Apr; 12(2):111-115. PubMed ID: 29029862
[TBL] [Abstract][Full Text] [Related]
55. Pedobarography - a novel screening tool for diabetic peripheral neuropathy?
Fang F; Wang YF; Gu MY; Chen H; Wang DM; Xiao K; Yan S; Yao LL; Li N; Zhen Q; Peng YD
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(23):3206-12. PubMed ID: 24338463
[TBL] [Abstract][Full Text] [Related]
56. Validity of the Diabetic Neuropathy Score and Diabetic Neuropathy Examination score as screening tools for the detection of distal symmetrical diabetic neuropathy.
Liyanage PL; Lekamwasam S; Weerarathna TP
J Diabetes; 2012 Sep; 4(3):264-5. PubMed ID: 22507170
[No Abstract] [Full Text] [Related]
57. One-stop microvascular screening service: an effective model for the early detection of diabetic peripheral neuropathy and the high-risk foot.
Binns-Hall O; Selvarajah D; Sanger D; Walker J; Scott A; Tesfaye S
Diabet Med; 2018 Jul; 35(7):887-894. PubMed ID: 29608799
[TBL] [Abstract][Full Text] [Related]
58. [Vibration perception threshold in diagnosing diabetic peripheral neuropathy by receiver operating characteristic curve].
Hou Y; Liu S; Zhu T; Zhang H; Liu G; Zhu Y; Chen H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 37(9):951-6. PubMed ID: 23000772
[TBL] [Abstract][Full Text] [Related]
59. The role of serum methylglyoxal on diabetic peripheral and cardiovascular autonomic neuropathy: the ADDITION Denmark study.
Hansen CS; Jensen TM; Jensen JS; Nawroth P; Fleming T; Witte DR; Lauritzen T; Sandbaek A; Charles M; Fleischer J; Vistisen D; Jørgensen ME
Diabet Med; 2015 Jun; 32(6):778-85. PubMed ID: 25761542
[TBL] [Abstract][Full Text] [Related]
60. A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee.
Fedele D; Comi G; Coscelli C; Cucinotta D; Feldman EL; Ghirlanda G; Greene DA; Negrin P; Santeusanio F
Diabetes Care; 1997 May; 20(5):836-43. PubMed ID: 9135952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
